Log in using OpenID

North America Oxygen Therapy Market

North America Oxygen Therapy Devices Market was worth USD 0.84 billion in 2016 and estimated to be growing at a CAGR of 5.51%, to reach USD 1.1 billion by 2021.
North America Oxygen Therapy Market Competitive Landscape By 2021
The North America Oxygen Therapy Devices Market was worth USD 0.84 billion in 2016
and estimated to be growing at a CAGR of 5.51%, to reach USD 1.1 billion by 2021.
Oxygen therapy involves administering oxygen through an external device.
Oxygen Therapy devices are useful specially for people suffering from severe COPD or
cystic fibrosis who suffer from chronically low oxygen levels in their body. Advantages of
oxygen therapy also include increased mental stamina, aversion of heart failure, and an
enhanced breathing pattern. The administration and supply of supplementary oxygen have
turned into an indispensable part in the management of numerous diseases. Furthermore,
oxygen therapy is applicable to numerous diseases, for example, asthma, respiratory
distress syndrome, and obstructive sleep apnoea. Long-term oxygen treatments in patients
suffering from chronic lung disease are believed to enhance the length and the quality of
View Full Report:
The growth of the North-American oxygen therapy market is mainly driven by the wide
range of respiratory diseases and disorders caused by the high level of air pollution and
poor lifestyle choices. These are primarily characterized by low oxygen levels in the body,
which is also known as hypoxemia which eventually leads to damage to tissue cells,
causing shortness of breath, poor quality of life, and strain on the heart. Increasing number
of government initiatives to raise awareness about the diseases and the treatments
available for it has further aided the cause for the North American oxygen therapy market.
Initiatives such as National Asthma Education and Prevention Program (NAEPP), National
Asthma Control Initiative (NACI) are aimed at offering result-oriented solutions for ensuring
asthma control in the U.S.
Request for Sample:
Market Segmentation
Oxygen Source Equipment
Oxygen Concentrators
Fixed Oxygen Concentrators
Portable Oxygen Concentrators
Liquid Oxygen Devices
Oxygen Cylinders
Oxygen Delivery Devices
Oxygen Masks
Nasal Cannulas
Venturi Masks
Non-Rebreather Masks
Bag Valve Masks
Other Devices
Y-o-Y Growth Analysis, By Product
Market Attractiveness Analysis, By Product
Market Share Analysis, By Product
Stationary Oxygen Therapy Devices
Portable Oxygen Therapy Devices
Y-o-Y Growth Analysis, By Portability
Market Attractiveness Analysis, By Portability
Market Share Analysis, By Portability
Chronic Obstructive Pulmonary Disease
Asthma, Obstructive Sleep Apnea
Respiratory Distress Syndrome
Cystic Fibrosis
Y-o-Y Growth Analysis, By Application
Market Attractiveness Analysis, By Application
Market Share Analysis, By Application
End User
Home Care Settings
Ambulatory Surgical Centers & Physician Offices
Y-o-Y Growth Analysis, By End User
Market Attractiveness Analysis, By End User
Market Share Analysis, By End User
The North America oxygen therapy devices market is segmented into product type,
application and end user. On the basis of product, it is segmented into Oxygen Source
Equipment, Cylinders, Concentrators, Liquid Oxygen Devices, PAP, Oxygen Delivery
Device, Masks, Nasal Cannula, Venturi Mask, Non-Rebreather Mask, Bag Valve and
CPAP. Oxygen source equipment are expected to grow at 11% CAGR It is attributed to the
consolidation of this equipment in the extensive variety of uses as the first line of treatment.
On the basis of application, it is segmented into Chronic Obstructive Pulmonary Disease,
Asthma, Obstructive Sleep Apnoea, Respiratory Distress Syndrome, Cystic Fibrosis,
Pneumonia. Chronic obstructive pulmonary disease holds the largest share of the
application segment and it is anticipated to grow lucratively at a CAGR of over 10.5% over
the next five years. This is due to increasing popularity of supplemental administration in
conjunction with first line treatments available for COPD. Moreover, this treatment includes
faster response rates, reliability and portability, and above all improves chances of survival.
On the basis of end use it is segmented into Home Healthcare and Hospitals. Home health
care dominates the end-use segment, owing to the rise in elderly population coupled with
increasing number of patients with low mobility and long-term care requirement in
conditions such as Alzheimer’s disease.
Inquire Before Buying:
The North America region is geographically segmented into U.S. and Canada. The U.S. is
expected to lead the regional market due to rising instances of COPD among its citizens.
Technological advances and high awareness about the availability of treatment for a
number of chronic respiratory diseases are expected to drive the market in the coming
This market is extremely disjointed with numerous big and developing players operating in
the business. The major companies dominating the oxygen therapy devices market in this
region are Chart Industries Inc., Invacare Corporation, Becton, Dickinson and Company,
Smiths Medical, Teleflex Incorporated, Inogen, Inc., DeVilbiss Healthcare, Essex Industries,
Inc., Allied Healthcare Products Inc. and Respan Products Inc.
About Us:
Market Data Forecast is a firm working in the area of market research and business
intelligence. With rich experience in research across various business domains, we
cater to the needs of both individual and corporate clients. Our analyst team comprises
expert professionals in market research, who with their collective knowledge and
sksillset dedicatedly serve clients from various industries and regions.
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: [email protected]
Visit MarketDataForecast Blog @
View latest Press Releases of MDF @
Bhargav410   documents Email
Report inappropriate content